Nurse-Led BBTi for Post-stroke Insomnia

Insomnia Clinical Trial

Official title:

Effects of Nurse-Led Brief Behavioral Treatment for Insomnia Following Stroke: A Randomized Controlled Trial

Clinical Trial Details — Status: Completed

Administrative data

• NCT number: NCT04876001
• Other study ID #: IRB 2290/KEPK/II/2021
• Status: Completed
• Phase: N/A
• Start date: November 1, 2022
• Est. completion date: February 28, 2024

Study information

• Verified date: April 2024
• Source: Taipei Medical University
• Contact: n/a
• Is FDA regulated: No
• Study type: Interventional

Clinical Trial Summary

The current study aims to compare face-to-face and internet-based nurse-led BBTI compare to a wait-list conditions in the stroke population. This study is a parallel, three-arm, randomized controlled trial (RCT). Each participant will be randomized into one of the treatment arms; face-to-face BBTI, internet-based BBTI, and waiting-list. The BBTI, emphasizes behavioral aspects of insomnia care, arises from techniques of sleep restriction and stimulus control. The face-to-face and internet-based BBTI have equivalent content based on the standard portion. All participants will be asked to fill the online questionnaires at weeks 0 (baseline), 1 (mid-treatment), 2 (post-treatment), 4, and 12 (follow up). After the final follow-up, the waiting-list participants will be allowed to join the internet-based BBTI treatment. Our hypotheses are that patients with stroke who receive face-to-face or internet-based BBTI, compared to a wait-list condition, will experience fewer insomnia complaints.

Description:

Post-stroke insomnia is a common complaint with prevalence rates remain high. Patients suffering from insomnia following stroke could impair their health-related quality of life and negative rehabilitation outcomes. Identifying effective treatment in managing post-stroke insomnia has become clinically relevant.

Brief behavioral therapy for insomnia (BBTI), a 4-section of treatment for insomnia, has similar treatment components with CBTI, with the exception of cognitive therapy. Previous evidence found that both BBTI and CBTI have comparable effects on improving sleep quality and consolidation. Existing literature has suggested that BBTI was effective on mitigating primary and comorbid insomnia. Nonetheless, thus far, no study has explored its effects in stroke population. Of note, BBTI still requires certain contact with therapists. To enhance the widespread dissemination of BBTI, it is important to establish the internet-based BBTI treatment model (more flexible time schedule) to target more populations with insomnia. The recent study of the online tailored BBTI has proven the comparable effects to reduce insomnia severity in the general population. However, no study investigates the efficacy of internet-based nurse-led BBTI in the stroke population.

Recruitment information / eligibility

• Status: Completed
• Enrollment: 42
• Est. completion date: February 28, 2024
• Est. primary completion date: December 30, 2023
• Accepts healthy volunteers: No
• Gender: All
• Age group: 18 Years to 100 Years

Eligibility

Inclusion Criteria:

• Had diagnosed with stroke for at least 3 months (chronic phase)

• Had NIHSS score < 6

• Complain insomnia symptom based on the score of ISI> 7

• Having sufficient cognitive function to complete tasks,

• Able to access to internet

Exclusion Criteria:

• The people receiving BBTI and other psychological treatment for insomnia

• Doing shift work

• Having psychiatric disorders

• Being pregnant or breastfeeding

• Having other sleep disorders (e.g., sleep apnea)

• Drugs or alcohol abuse,

• Serious or unstable medical condition prior to the study

Related Conditions & MeSH terms

• Insomnia
• Sleep Initiation and Maintenance Disorders

Intervention

Behavioral:
• Brief Behavior Therapy for Insomnia
The BBTI consists of two in-person sessions on week 1 and 3 and two sessions on week 2 and 4 as the "booster" delivered by phone call.

Locations

Country	Name	City	State
Taiwan	Taipei Medical University	Taipei

Sponsors (1)

Lead Sponsor	Collaborator
Taipei Medical University

Country where clinical trial is conducted

Taiwan, 

References & Publications (1)

Hasan F, Gordon C, Wu D, Huang HC, Yuliana LT, Susatia B, Marta OFD, Chiu HY. Dynamic Prevalence of Sleep Disorders Following Stroke or Transient Ischemic Attack: Systematic Review and Meta-Analysis. Stroke. 2021 Jan;52(2):655-663. doi: 10.1161/STROKEAHA.120.029847. Epub 2021 Jan 7. — View Citation

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	Insomnia severity ("change" is being assessed)	Insomnia Severity Index (ISI) will be used to measure the concept of insomnia symptoms. The total score is 0-28, where cutoff point score> 7 indicated as the presence of insomnia. The higher scores indicate severe condition.	Baseline, week 2 (during the intervention), week 4 (immediately after the intervention), and week 12 (follow up).
Primary	Sleep parameters ("change" is being assessed)	The Sleep Diary (SD) will be used to measure the subjective sleep parameters, including total sleep time, sleep onset latency, wake after sleep onset, sleep efficiency, and sleep quality. The good result such as total sleep time between 6-8 hours, sleep onset latency less than 30 minutes, wake after sleep onset less than 30 minutes, sleep efficiency greater than 85%, and sleep quality is good.	Baseline and up to week 4 (immediately after the intervention)
Secondary	Depression ("change" is being assessed)	We will use the Patient Health Questionaire-9 (PHQ-9). The total score of 0-27 and cutoff point> 10 of the total score were indicated as having post-stroke depression. The higher scores indicate more depression.	Baseline, week 2 (during the intervention), week 4 (immediately after the intervention), and week 12 (follow up).
Secondary	Anxiety ("change" is being assessed)	We will use the Generalized Anxiety Disorder-7 (GAD-7). The total score of 0-21 and cutoff point> 8 of the total score were indicated as having anxiety. The higher scores indicate more anxiety.	Baseline, week 2 (during the intervention), week 4 (immediately after the intervention), and week 12 (follow up).
Secondary	Fatigue ("change" is being assessed)	We will use the Fatigue Assessment Scale (FAS). The total score of 10-50 and the cutoff point> 22 was considered of having fatigue. The higher scores indicate more fatigue.	Baseline, week 2 (during the intervention), week 4 (immediately after the intervention), and week 12 (follow up).
Secondary	Sleepiness ("change" is being assessed)	We will use the Epworth Sleepiness Scale (ESS). The total score is 0-24 with cutoff point>10 were considered of having excessive daytime sleepiness. The higher scores indicate greater excessive daytime sleepiness.	Baseline, week 2 (during the intervention), week 4 (immediately after the intervention), and week 12 (follow up).